Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aurobindo Pharma Limited
AUROPHARMACurrent price
1 407.2 INR
+10.75 INR (+0.77%)
Last closed
1 394 INR
Company
www.aurobindo.com
ISIN
INE406A01037
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
809 637 969 905 INR
Yield for 12 month
+60.27 %
1Y
3Y
5Y
10Y
15Y
AUROPHARMA
Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India. Address: Galaxy, Plot No. 1, Hyderabad, India, 500032
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
80 176.43 INRP/E ratio
23.214Dividend Yield
0.32 %Current Year
+290 018 700 003 INR
Last Year
+246 171 299 969 INR
Current Quarter
+75 670 200 000 INR
Last Quarter
+75 801 499 962 INR
Current Year
+109 543 700 023 INR
Last Year
+133 238 699 973 INR
Current Quarter
+30 182 100 029 INR
Last Quarter
+31 386 200 035 INR
Key Figures AUROPHARMA
1 year
3 years
5 years
10 years
EBITDA
62 172 225 505 INR
Operating Margin TTM
PE Ratio
23.214
Return On Assets TTM
6.46 %
PEG Ratio
–
Return On Equity TTM
11.18 %
Wall Street Target Price
80 176.43 INR
Revenue TTM
297 183 707 136 INR
Book Value
509.32 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
10.5 %
Dividend Yield
0.32 %
Gross Profit TTM
135 621 200 000 INR
Earnings per share
60.05 INR
Diluted Eps TTM
60.05 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
61.1 %
Profit Margin
11.85 %
Dividend Analytics AUROPHARMA
Dividend growth over 5 years
167 %Continuous growth
–Payout Ratio 5 years average
10 %Dividend History AUROPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
4.5
Ex Dividend Date
20.02.2024
Forward Annual Dividend Yield
0.32 %
Last Split Factor
2:1
Payout Ratio
9.12 %
Last Split Date
20.07.2015
Dividend Date
–
Stock Valuation AUROPHARMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
23.214
Forward PE
8.3612
Enterprise Value Revenue
2.7725
Price Sales TTM
2.7244
Enterprise Value EBITDA
12.0035
Price Book MRQ
2.7179
Financials AUROPHARMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AUROPHARMA
For 52 weeks
867.39 INR
1 592 INR
50 Day MA
1 495.01 INR
Shares Short Prior Month
–
200 Day MA
1 267.85 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart